{"id":12236,"date":"2025-01-14T17:25:10","date_gmt":"2025-01-14T16:25:10","guid":{"rendered":"https:\/\/valintermed.com\/?p=12236"},"modified":"2025-01-14T17:25:10","modified_gmt":"2025-01-14T16:25:10","slug":"neyrofibromatoz-2-tipa-nf2","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/neurofibromatosis-type-2-nf2\/","title":{"rendered":"Neurofibromatosis type 2 (NF2)"},"content":{"rendered":"
<\/div>\n

Neurofibromatosis type 2 (NF2) is an autoimmune genetic syndrome characterized by the formation of multiple neurofibromas, especially in the auditory nerves, leading to deafness and other neurological disorders. The disease is hereditary and is caused by mutations in the NF2 gene, located on chromosome 22. The main and most pronounced clinical feature of NF2 is the development of bilateral acoustic neuromas (schwannomas), which lead to hearing impairment and may also cause other neurological manifestations due to compression of surrounding structures. The disease can also lead to the formation of other types of tumors, such as meningiomas and neurofibromas, which makes it difficult to diagnose and treat.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n